why choose us

First received: October 11, 2023

Clinical Trial: Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment

Study Status: Completed

Recruit Status: RECRUITING

Condition: Opioid Abuse

Study Type: OBSERVATIONAL


Official Title: Buprenorphine Induction and Naloxone Distribution Program-Combined With Warm Hand-Off Referral to Continued Treatment

Brief Summary: This study is a collaboration between the University of Utah and Castleview Hospital in Price, Utah.Buprenorphine is a medication approved by the FDA to treat Opioid Use Disorder (OUD).Castleview Hospital currently does not prescribe buprenorphine in the emergency department (ED) instead it refers patients to outside addiction treatment facilities.This is a service focused project which the University of Utah will provide mentoring and education to Castleview in implementing an in ED buprenorphine/naloxone…

Read more